Compare Equinor ASA (EQNR) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinor ASA vs Mesoblast Limited — how do they compare? Equinor ASA trades at $40.93 (market cap $97.58B), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Equinor ASA is far larger — about 44.2× Mesoblast Limited's market cap, and Equinor ASA pays a 3.81% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| EQNR | MESO | |
|---|---|---|
Market Cap | $97.58B | $2.21B |
Sector | Energy | Technology |
52-Week High | $42.40 | $20.96 |
52-Week Low | $22.41 | $12.88 |
Enterprise Value | $106.28B | $2.21B |
Dividend Yield | 3.81% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
